These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5828799)

  • 1. [Raubasine in arterial pathology of the extremities].
    Perrin M
    Lyon Med; 1965 May; 213(21):1585-90. PubMed ID: 5828799
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical action in vascular pathology of the limbs, of an original association of raubasine and 711 SE].
    Bouret G; Coget JM; Merlen JF; Warembourg H
    Lille Med; 1970 Mar; 15(3 Suppl 2):440-3. PubMed ID: 5421804
    [No Abstract]   [Full Text] [Related]  

  • 3. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases].
    Sforza M; Perelli-Ercolini M
    Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of a delayed-action preparation of beta pyridyl-carbinol in vascular pathology].
    Warembourg H; Thery C
    Lille Med; 1970 Apr; 15(4 Suppl 3):599-602. PubMed ID: 5424406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
    Giubbolini G; Setacci C; Romei R; Federici L
    Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardilan in the treatment of obliterative diseases of peripheral arteries].
    Ginko T; Adamczyk R; Dyaczyńska A
    Wiad Lek; 1971 Jun; 24(12):1211-5. PubMed ID: 5561279
    [No Abstract]   [Full Text] [Related]  

  • 10. [Do indications still exist for intra-arterial infiltrations in vascular pathology?].
    Lagadec B; Vergoz L
    Phlebologie; 1979; 32(1):53-6. PubMed ID: 432290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute effect of intravenous administration of raubasine on the peripheral pulse in patients with diabetic arterial diseases].
    Calcaterra V
    Minerva Cardioangiol; 1973; 21(7):530-44. PubMed ID: 4756347
    [No Abstract]   [Full Text] [Related]  

  • 12. [The management of ocular circulatory disturbances with lamuran].
    Genée E
    Klin Monbl Augenheilkd; 1969 Dec; 155(6):850-4. PubMed ID: 4312485
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood pressure behavior under high dosage of raubasine in man].
    Krönig B; Schwarz W; Parade D; Jahnecke J
    Verh Dtsch Ges Inn Med; 1971; 77():1013-7. PubMed ID: 5155953
    [No Abstract]   [Full Text] [Related]  

  • 14. [Defluine (an association of raubasine and ergot derivatives) in the treatment of senile cerebral vascular diseases of a sclerotic nature].
    Turri C
    Minerva Med; 1970 Aug; 61(65):3466-76. PubMed ID: 5451093
    [No Abstract]   [Full Text] [Related]  

  • 15. [Raubasine in combination with ergot alkaloid derivatives in the therapy of closed injuries of the brain].
    Stoppani L
    Arch Sci Med (Torino); 1965 Nov; 120(5):431-9. PubMed ID: 4956319
    [No Abstract]   [Full Text] [Related]  

  • 16. [Report on the clinical trial with lamuran (II)].
    Steinorth G
    Med Welt; 1967 Sep; 36():2110-5. PubMed ID: 5614247
    [No Abstract]   [Full Text] [Related]  

  • 17. [On a case of Lermoyez' disease, treated by Raubasine].
    Alavoine J
    Ann Otolaryngol Chir Cervicofac; 1968 Dec; 85(8):801-4. PubMed ID: 5728715
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a xanthine derivative in peripheral arterial blood flow disorders].
    de Weger WP
    Med Monatsschr; 1970 May; 24(5):221-5. PubMed ID: 5512478
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in blood serum protein fractions in obliterating vascular diseases of the extremities following nivaline-electrophoresis therapy].
    Todorov N
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):512-6. PubMed ID: 5515367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Continuous intra-arterial perfusion of long duration. Its place in the treatment of degenerative arteriopathies of the lower extremities].
    Debry G; Tran Quang-Kien
    Presse Med (1893); 1965 Sep; 73(40):2243-6. PubMed ID: 5828431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.